HCW Biologics (HCWB) Misses Q2 EPS by 679c

HCW Biologics (NASDAQ: HCWB) reported Q2 EPS of ($6.79). Revenue for the quarter came in at $1.31 million.

For earnings history and earnings-related data on HCW Biologics (HCWB) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance